TITLE
Glycogen synthase kinase 3 inhibitor effect on MLL leukemia cells

SUMMARY
Analysis of MLL leukemia cell line RS4.11 treated with GSK-3 inhibitor SB216763 for 20 hours. Results provide insight into the molecular mechanisms underlying MLL leukemia dependence on GSK-3.

ORGANISM
Homo sapiens

PLATFORM
GPL6244 : [HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version]

CITATIONS
Wang Z, Iwasaki M, Ficara F, Lin C et al. GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis. Cancer Cell 2010 Jun 15;17(6):597-608. PMID:Â  20541704

